[1]
|
Tangye, S.G., Al-Herz, W., Bousfiha, A., et al. (2022) Human Inborn Errors of Immunity: 2022 Update on the Classifi-cation from the International Union of Immunological Societies Expert Committee. Journal of Clinical Immunology, 42, 1473-1507. https://doi.org/10.1007/s10875-022-01289-3
|
[2]
|
Fischer, A., Notarangelo, L.D., Neven, B., et al. (2015) Severe Combined Immunodeficiencies and Related Disorders. Nature Reviews Disease Primers, 1, Article No. 15061. https://doi.org/10.1038/nrdp.2015.61
|
[3]
|
杜鸿强, 安云飞, 赵晓东. 不典型重症联合免疫缺陷病的临床研究进展[J]. 中华儿科杂志, 2014, 52(12): 906-909.
|
[4]
|
Gao, Z.W., Wang, X., Zhang, H.Z., et al. (2021) The Roles of Adenosine Deaminase in Autoimmune Diseases. Autoimmunity Reviews, 20, Article ID: 102709. https://doi.org/10.1016/j.autrev.2020.102709
|
[5]
|
Valerio, D., Duyvesteyn, M.G., Dekker, B.M., et al. (1985) Adenosine Deaminase: Characterization and Expression of a Gene with a Remarkable Promoter. The EMBO Journal, 4, 437-443.
https://doi.org/10.1002/j.1460-2075.1985.tb03648.x
|
[6]
|
Arredondo-Vega, F.X., Santisteban, I., Daniels, S., et al. (1998) Adenosine Deaminase Deficiency: Genotype-Phenotype Correlations Based on Expressed Activity of 29 Mutant Alleles. The American Journal of Human Genetics, 63, 1049- 1059. https://doi.org/10.1086/302054
|
[7]
|
Essadssi, S., Krami, A.M., Elkhattabi, L., et al. (2019) Computational Analysis of nsSNPs of ADA Gene in Severe Combined Immunodeficiency Using Molecular Modeling and Dynamics Simulation. Journal of Immunology Research, 2019, Article ID: 5902391. https://doi.org/10.1155/2019/5902391
|
[8]
|
Kwan, A., Abraham, R.S., Currier, R., et al. (2014) Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States. JAMA, 312, 729-738. https://doi.org/10.1001/jama.2014.9132
|
[9]
|
Flinn, A.M. and Gennery, A.R. (2018) Adeno-sine Deaminase Deficiency: A Review. Orphanet Journal of Rare Diseases, 13, 65. https://doi.org/10.1186/s13023-018-0807-5
|
[10]
|
Santisteban, I., Arredondo-Vega, F.X., Kelly, S., et al. (1995) Three New Adenosine Deaminase Mutations That Define a Splicing Enhancer and Cause Severe and Partial Phenotypes: Implications for Evolution of a CpG Hotspot and Expression of a Transduced ADA cDNA. Human Molecular Genetics, 4, 2081-2087.
https://doi.org/10.1093/hmg/4.11.2081
|
[11]
|
Blackburn, M.R. and Thompson, L.F. (2012) Adenosine Deaminase Deficiency: Unanticipated Benefits from the Study of a Rare Immunodeficiency. The Journal of Immunology, 188, 933-935. https://doi.org/10.4049/jimmunol.1103519
|
[12]
|
Dorsey, M.J., Dvorak, C.C., Cowan, M.J., et al. (2017) Treatment of Infants Identified as Having Severe Combined Immunodeficiency by Means of Newborn Screening. Jour-nal of Allergy and Clinical Immunology, 139, 733-742.
https://doi.org/10.1016/j.jaci.2017.01.005
|
[13]
|
Felgentreff, K., Perez-Becker, R., Speckmann, C., et al. (2011) Clinical and Immunological Manifestations of Patients with Atypical Severe Combined Immunodeficiency. Clinical Im-munology, 141, 73-82.
https://doi.org/10.1016/j.clim.2011.05.007
|
[14]
|
Bousfiha, A., Jeddane, L., Picard, C., et al. (2020) Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. Journal of Clinical Immunology, 40, 66-81. https://doi.org/10.1007/s10875-020-00758-x
|
[15]
|
Bradford, K.L., Moretti, F.A., Carbonaro-Sarracino, D.A., et al. (2017) Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations. Journal of Clinical Immunology, 37, 626-637. https://doi.org/10.1007/s10875-017-0433-3
|
[16]
|
Al-Shaikhly, T. and Ochs, H.D. (2019) Hyper IgE syndromes: Clinical and Molecular Characteristics. Immunology & Cell Biology, 97, 368-379. https://doi.org/10.1111/imcb.12209
|
[17]
|
Noordzij, J.G., De Bruin-Versteeg, S., Verkaik, N.S., et al. (2002) The Immunophenotypic and Immunogenotypic B-Cell Differentiation Arrest in Bone Marrow of RAG-Deficient SCID Pa-tients Corresponds to Residual Recombination Activities of Mutated RAG Proteins. Blood, 100, 2145-2152.
|
[18]
|
Sauer, A.V., Brigida, I., Carriglio, N., et al. (2012) Autoimmune Dysregulation and Purine Metabolism in Adenosine Deami-nase Deficiency. Frontiers in Immunology, 3, 265. https://doi.org/10.3389/fimmu.2012.00265
|
[19]
|
Whitmore, K.V. and Gaspar, H.B. (2016) Adenosine Deaminase Deficiency—More Than Just an Immunodeficiency. Frontiers in Im-munology, 7, 314. https://doi.org/10.3389/fimmu.2016.00314
|
[20]
|
Sokolic, R., Maric, I., Kesserwan, C., et al. (2011) Myeloid Dysplasia and Bone Marrow Hypocellularity in Adenosine Deaminase-Deficient Severe Combined Im-mune Deficiency. Blood, 118, 2688-2694.
https://doi.org/10.1182/blood-2011-01-329359
|
[21]
|
Tsui, M., Min, W., Ng, S., et al. (2021) The Use of Induced Pluripotent Stem Cells to Study the Effects of Adenosine Deaminase Deficiency on Human Neutrophil Development. Frontiers in Immunology, 12, Article ID: 748519.
https://doi.org/10.3389/fimmu.2021.748519
|
[22]
|
Blackburn, M.R., Volmer, J.B., Thrasher, J.L., et al. (2000) Metabolic Consequences of Adenosine Deaminase Deficiency in Mice Are Associated with Defects in Alveogenesis, Pulmonary Inflammation, and Airway Obstruction. Journal of Experimental Medicine, 192, 159-170. https://doi.org/10.1084/jem.192.2.159
|
[23]
|
Zhou, Y., Mohsenin, A., Morschl, E., et al. (2009) Enhanced Airway Inflammation and Remodeling in Adenosine Deaminase-Deficient Mice Lacking the A2B Adenosine Receptor. The Journal of Immunology, 182, 8037-8046.
https://doi.org/10.4049/jimmunol.0900515
|
[24]
|
Booth, C., Algar, V.E., Xu-Bayford, J., et al. (2012) Non-Infectious Lung Disease in Patients with Adenosine Deaminase Deficient Severe Combined Immunodeficiency. Journal of Clinical Immunology, 32, 449-453.
https://doi.org/10.1007/s10875-012-9658-3
|
[25]
|
Sauer, A.V., Mrak, E., Hernandez, R.J., et al. (2009) ADA-Deficient SCID Is Associated with a Specific Microenvironment and Bone Phenotype Characterized by RANKL/OPG Imbalance and Osteoblast Insufficiency. Blood, 114, 3216-3226. https://doi.org/10.1182/blood-2009-03-209221
|
[26]
|
Kuo, C.Y., Garabedian, E., Puck, J., et al. (2020) Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry. Journal of Clinical Immunology, 40, 1124-1131. https://doi.org/10.1007/s10875-020-00857-9
|
[27]
|
Xu, X., Negandhi, J., Min, W., et al. (2019) Early Enzyme Re-placement Therapy Improves Hearing and Immune Defects in Adenosine Deaminase Deficient-Mice. Frontiers in Im-munology, 10, 416.
https://doi.org/10.3389/fimmu.2019.00416
|
[28]
|
Kohn, D.B., Hershfield, M.S., Puck, J.M., et al. (2019) Consensus Approach for the Management of Severe Combined Immune Deficiency Caused by Adenosine Deaminase Deficiency. Journal of Allergy and Clinical Immunology, 143, 852-863. https://doi.org/10.1016/j.jaci.2018.08.024
|